What rheumatic diseases have been treated successfully with MMF? Which diseases have not been treated successfully with MMF?
Use is similar to AZA. Good success has been seen in lupus nephritis (diffuse proliferative glomerulonephritis membranous) especially in African-American and Hispanic patients. It has been used successfully for treating cutaneous lupus (discoid and subacute cutaneous lupus), systemic sclerosis, myositis, uveitis, and vasculitis. Patients with RA or psoriatic arthritis (PsA) usually do not respond to MMF. MMF is also less effective than AZA in maintaining remission in patients with granulomatous polyangiitis. Due to its lymphocyte and antifibrotic effects, it has been effective in treating interstitial lung disease (ILD) associated with many rheumatic diseases.
